Cobalamin (Vitamin B12) status in patients with antiphospholipid syndrome (APS), its association with atherosclerotic vascular lesions

dc.contributor.author	Segeda, I.	en
dc.contributor.author	Shevchuk, S.	en
dc.contributor.author	Kuvikova, I.	en
dc.contributor.author	Shevchuk, O.	en
dc.date.accessioned	2020-02-11T11:17:42Z
dc.date.available	2020-02-11T11:17:42Z
dc.date.issued	2017
dc.identifier.citation	Cobalamin (Vitamin B12) status in patients with antiphospholipid syndrome (APS), its association with atherosclerotic vascular lesions / I. Segeda, S. Shevchuk, I. Kuvikova, O. Shevchuk // Ann. Rheum. Dis. – 2017. – Vol. 76, issue suppl. 2. – P. 1228-1229.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/4347
dc.description.abstract	To evaluate vitamin B12 status in patients with antiphospholipid syndrome (APS) and to explore its relationship with atherosclerotic vascular lesion 82 patients with APS and 37 healthy individuals were observed. Content of cobalamin (vitamin B12) in serum were determined by immunochemical detection (ECLIA). It was founded that in patients with APS low cobalamin status is associated with subclinical manifestations of atherosclerotic vascular lesions.	en
dc.language.iso	en	en
dc.subject	Cobalamin (Vitamin B12)	en
dc.subject	antiphospholipid syndrome	en
dc.subject	atherosclerotic vascular lesions	en
dc.subject	immunochemical detection	en
dc.title	Cobalamin (Vitamin B12) status in patients with antiphospholipid syndrome (APS), its association with atherosclerotic vascular lesions	en
dc.type	Thesis	en